(Q33822518)

English

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

type-1 diabetes

0 references

author name string

V M Monnier

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

O Bautista

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

D Kenny

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

D R Sell

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J Fogarty

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

W Dahms

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

P A Cleary

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J Lachin

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

S Genuth

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

870-880

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2862597

4 July 2018

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2862597

4 July 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2862597

4 July 2018

Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2862597

4 July 2018

The clinical information value of the glycosylated hemoglobin assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2862597

4 July 2018

Accelerated age-related browning of human collagen in diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2862597

4 July 2018

Relationship between the content of lysyl oxidase-dependent cross-links in skin collagen, nonenzymatic glycosylation, and long-term complications in type I diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2862597

4 July 2018

Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2862597

4 July 2018

Glycation products and the pathogenesis of diabetic complications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2862597

4 July 2018

Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2862597

4 July 2018

Relationship between glycemic control and collagen-linked advanced glycosylation end products in type I diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2862597

29 October 2018

Improved metabolic control in patients with non-insulin-dependent diabetes mellitus is associated with a slower accumulation of glycation products in collagen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2862597

29 October 2018

Reliable determination of furosine in human serum and dialysate proteins by high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between complications of type I diabetes mellitus and collagen-linked fluorescence

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. The DCCT Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aldimine to ketoamine isomerization (Amadori rearrangement) potential at the individual nonenzymic glycation sites of hemoglobin A: preferential inhibition of glycation by nucleophiles at sites of low isomerization potential

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10102706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2337/DIABETES.48.4.870

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33822518&oldid=1952700807"